“Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s737. doi:10.25251/0y59xj91.